| NERV Stock | | | USD 2.26 0.02 0.89% |
Minerva Neurosciences financial indicator trend analysis is infinitely more than just investigating Minerva Neurosciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Minerva Neurosciences is a good investment. Please check the relationship between Minerva Neurosciences Deferred Long Term Liab and its Accounts Payable accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Minerva Stock please use our
How to Invest in Minerva Neurosciences guide.
Deferred Long Term Liab vs Accounts Payable
Deferred Long Term Liab vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Minerva Neurosciences Deferred Long Term Liab account and
Accounts Payable. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Minerva Neurosciences' Deferred Long Term Liab and Accounts Payable is -0.2. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Minerva Neurosciences, assuming nothing else is changed. The correlation between historical values of Minerva Neurosciences' Deferred Long Term Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Minerva Neurosciences are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Deferred Long Term Liab i.e., Minerva Neurosciences' Deferred Long Term Liab and Accounts Payable go up and down completely randomly.
Correlation Coefficient | -0.2 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.
Accounts Payable
An accounting item on the balance sheet that represents Minerva Neurosciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Minerva Neurosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Minerva Neurosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Minerva Neurosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Minerva Stock please use our
How to Invest in Minerva Neurosciences guide.At this time, Minerva Neurosciences'
Selling General Administrative is fairly stable compared to the past year.
Tax Provision is expected to grow at the current pace this year, whereas
Enterprise Value Over EBITDA is likely to drop
(3.92) in 2024.
Minerva Neurosciences fundamental ratios Correlations
Click cells to compare fundamentals
Minerva Neurosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Minerva Neurosciences fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to
measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to
predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.